SCI Pharmtech Corp. (4119) Stock Price & Analysis
4119 Stock Chart & Stats
- Day’s Range
- TWD 47.15 - TWD 50.70
- 52-Week Range
- TWD 39.60 - TWD 60.70
- Previous Close
- TWD 50.60
- Volume
- N/A
- Average Volume (3M)
- 106.38K
- Market Cap
- TWD 5.92B
- Enterprise Value
- TWD 6.33B
- Total Cash (Recent Filing)
- TWD 84.07M
- Total Debt (Recent Filing)
- TWD 1.06B
- Price to Earnings (P/E)
- 100.6
- Beta
- 0.30
- Next Earnings
- Mar 16, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 01, 2026
- Dividend Yield
- 1.51%
4119 FAQ
What was SCI Pharmtech Corp.’s price range in the past 12 months?
What is SCI Pharmtech Corp.’s market cap?
When is SCI Pharmtech Corp.’s upcoming earnings report date?
How were SCI Pharmtech Corp.’s earnings last quarter?
Is SCI Pharmtech Corp. overvalued?
Does SCI Pharmtech Corp. pay dividends?
What is SCI Pharmtech Corp.’s EPS estimate?
How many shares outstanding does SCI Pharmtech Corp. have?
What happened to SCI Pharmtech Corp.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of SCI Pharmtech Corp.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
SCI Pharmtech Corp.
SCI Pharmtech, Inc., founded in 1987 and based in Taoyuan City, Taiwan, specializes in the comprehensive lifecycle of pharmaceutical components. The company's core operations involve the research and development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs), chemical intermediates, and specialty chemicals. Its extensive portfolio of APIs includes critical compounds such as Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Cannabidiol, and Dexmethylphenidate HCl, among many others. Additionally, SCI Pharmtech produces a wide array of intermediate products, featuring substances like Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Pyrogallolaldehyde, and various specialized esters and alcohols, which serve as essential building blocks in chemical synthesis. Beyond its standard product lines, the company also offers custom manufacturing services tailored to specific client needs. SCI Pharmtech maintains a robust international presence, distributing its products to significant markets across the globe, including Italy, China, the United States, Germany, Taiwan, Switzerland, Spain, Japan, and the Netherlands.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wen-Chih Chou
- Employees
- 202
- Website
- www.sci-pharmtech.com.tw
- Address
- No. 61, Haihu North Road, Taoyuan City, TYN, 33856, TW
SCI Pharmtech Corp. (4119) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 5 | 14 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 0 | 0 | 12 |

